Article
De novo recurrent germline mutation of the BRCA2 gene in a patient with early onset breast cancer.
Journal of medical genetics - 1 Feb 2001
van der Luijt R B, van Zon P H, Jansen R P, van der Sijs-Bos C J, Wárlám-Rodenhuis C C, Ausems M G
Abstract excerpt
Germline mutations in either of the two major breast cancer predisposition genes, BRCA1 and BRCA2, account for a significant proportion of hereditary breast/ovarian cancer. Identification of breast cancer patients carrying mutations of these genes is primarily based on a positive family history of breast/ovarian cancer or early onset of the disease or both. In the course of mutation screening of the BRCA1 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
